Home NDC 81665-300 NUMBRINO
Product NDC 81665-300
11-digit product format 816650300
Labeler code 81665
Product ID 81665-300_b722df62-ac8d-49c0-b357-c814b89471fe
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name cocaine hydrochloride nasal
Dosage form SOLUTION
Route TOPICAL
Labeler OMNIVIUM PHARMACEUTICALS LLC.
Application NDA209575
Marketing category NDA
Marketing start 2024-06-19
Substance COCAINE HYDROCHLORIDE
Active strength 40 mg/mL
DEA schedule CII
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209575-001 NUMBRINO COCAINE HYDROCHLORIDE 4% SOLUTION / NASAL RLD, RS 2020-01-10
Orange Book patents# Current patent rows page 1 of 1 · 18 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N209575-001 NUMBRINO 4% SOLUTION / NASAL 2020-01-10 c0c555d07b60…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N209575-001 NUMBRINO 4% SOLUTION / NASAL RLD, RS 2020-01-10 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 10 · 378 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N209575-001 10016407 2037-02-07 U-2225 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10016407 2037-02-07 U-2226 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10016407 2037-02-07 U-2329 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10149843 2037-02-07 U-2478 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10149843 2037-02-07 U-2479 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10231961 2037-02-07 Drug product 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10413505 2037-02-07 U-3014 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10420760 2037-02-07 U-2478 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10857095 2037-02-07 U-3014 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10894012 2037-02-07 U-3014 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10933060 2037-02-07 U-2478 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10933060 2037-02-07 U-3014 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 10973811 2037-02-07 U-3680 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 11040032 2037-02-07 Drug product 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 9867815 2037-02-07 U-2225 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 9867815 2037-02-07 U-2329 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 9867815 2037-02-07 U-2227 2023-08-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209575-001 9867815 2037-02-07 U-2226 2023-08-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209575-001 10016407 2037-02-07 U-2225 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10016407 2037-02-07 U-2226 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10016407 2037-02-07 U-2329 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10149843 2037-02-07 U-2478 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10149843 2037-02-07 U-2479 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10231961 2037-02-07 Drug product 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10413505 2037-02-07 U-3014 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10420760 2037-02-07 U-2478 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10857095 2037-02-07 U-3014 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10894012 2037-02-07 U-3014 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10933060 2037-02-07 U-2478 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10933060 2037-02-07 U-3014 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 10973811 2037-02-07 U-3680 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 11040032 2037-02-07 Drug product 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 9867815 2037-02-07 U-2225 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 9867815 2037-02-07 U-2329 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 9867815 2037-02-07 U-2227 2023-08-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209575-001 9867815 2037-02-07 U-2226 2023-08-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209575-001 10016407 2037-02-07 U-2225 2023-08-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209575-001 10016407 2037-02-07 U-2226 2023-08-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209575-001 10016407 2037-02-07 U-2329 2023-08-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209575-001 10149843 2037-02-07 U-2478 2023-08-28 31067a03dcf5…
Observed Orange Book exclusivity history# Additional Listing Data#
Finished product Yes
Brand name base NUMBRINO
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength COCAINE HYDROCHLORIDE 40 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination XH8T8T6WZH Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1995288 Internal RxNorm lookup 2272608 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 81665-300-02 NUMBRINO 1 in 1 CARTON SOLUTION 1 3 81665-300-02 NUMBRINO 4 mL in 1 BOTTLE, GLASS SOLUTION 4 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 81665-300 NUMBRINO (COCAINE HYDROCHLORIDE NASAL) SOLUTION [OMNIVIUM PHARMACEUTICALS LLC.] 2 Current NDC, 2 package rows 20240622_d724b5b4-6654-4bf5-9eed-e2c7943084ed.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 81665-300-02 81665030002 1 BOTTLE, GLASS in 1 CARTON (81665-300-02) / 4 mL in 1 BOTTLE, GLASS 2024-06-19 No No Current